Investors Menu

News Details

Eagle Pharmaceuticals to Present at Piper Jaffray 2014 Healthcare Conference


Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) (“Eagle” or the “Company”) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at the Piper Jaffray 26th Annual Healthcare Conference as follows:



Wednesday, December 3, 2014



2:00 p.m. EST



The New York Palace Hotel in New York City


The presentation will be webcast live at the aforementioned time and simultaneously available via the link provided, as well as archived for 90 days thereafter, via the Company’s website at, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. The Company’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at


In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793

Change % Volume Data as of 03/31/2023 11:39 PM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Contact

Communications, Inc.
Lisa M. Wilson,

For all other media inquiries, please contact us.